FAM
Fred Alger Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-165,317
| Closed | -$5.61M | – | 478 |
|
|
2023
Q2 | $5.61M | Sell |
165,317
-198,956
| -55% | -$6.75M | 0.03% | 240 |
|
|
2023
Q1 | $13.1M | Sell |
364,273
-156,599
| -30% | -$5.63M | 0.07% | 179 |
|
|
2022
Q4 | $23.2M | Buy |
520,872
+77,230
| +17% | +$3.44M | 0.13% | 154 |
|
|
2022
Q3 | $12.5M | Buy |
443,642
+200,259
| +82% | +$5.63M | 0.06% | 190 |
|
|
2022
Q2 | $6.56M | Buy |
243,383
+87,579
| +56% | +$2.36M | 0.03% | 239 |
|
|
2022
Q1 | $5.31M | Sell |
155,804
-346,321
| -69% | -$11.8M | 0.02% | 266 |
|
|
2021
Q4 | $19.4M | Sell |
502,125
-23,742
| -5% | -$917K | 0.05% | 209 |
|
|
2021
Q3 | $28.4M | Buy |
+525,867
| New | +$28.4M | 0.07% | 189 |
|
|
2016
Q4 | – | Sell |
-60,000
| Closed | -$242K | – | 491 |
|
|
2016
Q3 | $242K | Buy |
60,000
+6,800
| +13% | +$27.4K | ﹤0.01% | 371 |
|
|
2016
Q2 | $234K | Sell |
53,200
-191,942
| -78% | -$844K | ﹤0.01% | 409 |
|
|
2016
Q1 | $927K | Sell |
245,142
-95,433
| -28% | -$361K | ﹤0.01% | 382 |
|
|
2015
Q4 | $5.34M | Sell |
340,575
-35,632
| -9% | -$559K | 0.03% | 242 |
|
|
2015
Q3 | $3.97M | Sell |
376,207
-174,379
| -32% | -$1.84M | 0.02% | 294 |
|
|
2015
Q2 | $13.9M | Sell |
550,586
-5,537
| -1% | -$140K | 0.06% | 188 |
|
|
2015
Q1 | $15.5M | Sell |
556,123
-230,612
| -29% | -$6.43M | 0.07% | 209 |
|
|
2014
Q4 | $14.4M | Buy |
786,735
+111,163
| +16% | +$2.03M | 0.07% | 214 |
|
|
2014
Q3 | $8.76M | Sell |
675,572
-32,787
| -5% | -$425K | 0.04% | 279 |
|
|
2014
Q2 | $11.6M | Sell |
708,359
-21,600
| -3% | -$352K | 0.06% | 263 |
|
|
2014
Q1 | $12.9M | Sell |
729,959
-329,955
| -31% | -$5.83M | 0.06% | 274 |
|
|
2013
Q4 | $25.7M | Buy |
1,059,914
+704,754
| +198% | +$17.1M | 0.13% | 175 |
|
|
2013
Q3 | $12.6M | Buy |
+355,160
| New | +$12.6M | 0.07% | 269 |
|